SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-042626
Filing Date
2021-08-09
Accepted
2021-08-09 16:07:59
Documents
19
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20210809.htm   iXBRL 8-K 34649
2 EX-99.1 sndx-ex991_6.htm EX-99.1 231604
3 GRAPHIC gxhcwarmog25000001.jpg GRAPHIC 34522
4 GRAPHIC gxhcwarmog25000002.jpg GRAPHIC 34522
5 GRAPHIC gxhcwarmog25000004.jpg GRAPHIC 34522
6 GRAPHIC gxhcwarmog25000005.jpg GRAPHIC 34522
7 GRAPHIC gxhcwarmog25000006.jpg GRAPHIC 34522
8 GRAPHIC gxhcwarmog25000003.jpg GRAPHIC 34522
  Complete submission text file 0001564590-21-042626.txt   703515

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210809.xsd EX-101.SCH 5768
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210809_lab.xml EX-101.LAB 20987
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210809_pre.xml EX-101.PRE 12537
12 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20210809_htm.xml XML 3794
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 211156510
SIC: 2834 Pharmaceutical Preparations